| Entry |
|
|---|
| Name |
Interferon alfa-2a (USAN/INN);
Interferon alfa-2a (genetical recombination) (JAN);
Roferon A (TN) |
|---|
| Formula |
C860H1353N227O255S9
|
|---|
| Exact mass |
19228.7369
|
|---|
| Mol weight |
19240.8977
|
|---|
| Sequence |
CDLPQTHSLG SRRTLMLLAQ MRKISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI
QQIFNLFSTK DSSAAWDETL LDKFYTELYQ QLNDLEACVI QGVGVTETPL MKEDSILAVR
KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE |
|---|
| Type |
Peptide |
|---|
| Class |
Immunological agent
DG01752 Interferone
|
|---|
| Remark |
| Product (DG01750): | D03305<JP> |
|
|---|
| Efficacy |
Antineoplastic, Biological response modifier |
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04650 | Natural killer cell mediated cytotoxicity |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB04 Interferon alfa-2a
D00745 Interferon alfa-2a (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01750 Interferon alpha
D00745 Interferon alfa-2a
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D00745 Interferon alfa-2a (USAN/INN)
IFNAR2
D00745 Interferon alfa-2a (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01750 Interferon alpha
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
DG01750 Interferon alpha
|
|---|
| Other DBs |
|
|---|
